Skip to main content

Breadcrumb

  1. Home

Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

2019-06 TRISCEND Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about 2019-06 TRISCEND Study

Developing and Pilot Testing an Opioid Tapering Protocol

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Developing and Pilot Testing an Opioid Tapering Protocol

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

ZZ06 in Adult Patients With Advanced EGFR Positive Solid Tumor Malignancies

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about ZZ06 in Adult Patients With Advanced EGFR Positive Solid Tumor Malignancies

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

An Open Label Study of FT218 in Subjects With Narcolepsy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about An Open Label Study of FT218 in Subjects With Narcolepsy

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Donor After Circulatory Death Heart CAP Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Donor After Circulatory Death Heart CAP Trial

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 224
  • Page 225
  • Page 226
  • Page 227
  • Page 228
  • Page 229
  • Page 230
  • Page 231
  • Page 232
  • …
  • Next page Next
  • Last page Last
Subscribe to